Hepatitis B isn't often discussed by Asian Americans, but this ad will get you talking. San Francisco Hep B Free launched "Which One Deserves To Die?," a provocative ad campaign alerting the Asian American community that 1 in 10 Asian Americans is chronically infected with hepatitis B compared to 1 in 1,000 in the general population. This in your face ad shows why we as Asian Americans need to be tested for hepatitis B. This million dollar ad campaign will appear in ethnic and local newspapers, billboards, bus shelters for the month of May. TV commercials were also produced and will be shown on cable, broadcast and Asian television.
Monday, May 3, 2010
Which One Deserves To Die? – Hepatitis B Ad
Published on Channel APA

Hepatitis B isn't often discussed by Asian Americans, but this ad will get you talking. San Francisco Hep B Free launched "Which One Deserves To Die?," a provocative ad campaign alerting the Asian American community that 1 in 10 Asian Americans is chronically infected with hepatitis B compared to 1 in 1,000 in the general population. This in your face ad shows why we as Asian Americans need to be tested for hepatitis B. This million dollar ad campaign will appear in ethnic and local newspapers, billboards, bus shelters for the month of May. TV commercials were also produced and will be shown on cable, broadcast and Asian television.
Hepatitis B isn't often discussed by Asian Americans, but this ad will get you talking. San Francisco Hep B Free launched "Which One Deserves To Die?," a provocative ad campaign alerting the Asian American community that 1 in 10 Asian Americans is chronically infected with hepatitis B compared to 1 in 1,000 in the general population. This in your face ad shows why we as Asian Americans need to be tested for hepatitis B. This million dollar ad campaign will appear in ethnic and local newspapers, billboards, bus shelters for the month of May. TV commercials were also produced and will be shown on cable, broadcast and Asian television.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment